KSC · 009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
₩6,230-₩80 (-1.27%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.33% below the high.
Loading market information…
KSC · 007570.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:19 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Ilyang Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 56.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ilyang Pharmaceutical Co.,Ltd’s forward annual dividend is ₩155 per share, paid annual. The forward yield is 2.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ilyang Pharmaceutical Co.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Yongin, South Korea, Ilyang Pharmaceutical Co.,Ltd is a prominent pharmaceutical enterprise that has been operating since its establishment in 1946. The company, which was formerly known as Il-Yang Pharm. Ind. Co. until its renaming in May 1991, primarily conducts its business in South Korea. It develops and provides a comprehensive portfolio of medicines addressing various therapeutic areas, such as oncology, cardiovascular health, endocrine and metabolic conditions, women's health (including female hormone treatments and cheonjiyang), urology, ophthalmology, liver diseases, pain and inflammation, digestive system issues, dermatological complaints, and respiratory illnesses. Their pharmaceutical offerings also extend to nutrient infusions, neurological medications, antibiotics, antifungals, insecticides, and vaccines. In addition to medicinal products, Ilyang manufactures a range of consumer health items, including health drinks, dietary supplements, health foods, cosmetics, and other beverages. The company is also a producer of numerous pharmaceutical raw materials, specifically various aluminum and magnesium compounds. Ilyang Pharmaceutical has an international footprint, exporting its diverse product range to roughly 14 countries worldwide.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:49 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩6,230-₩80 (-1.27%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.33% below the high.
₩3,935-₩65 (-1.63%)
JW Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.
₩19,100-₩270 (-1.39%)
Samjin Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.25% below the high.
₩9,370+₩10 (+0.11%)
REYON Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.02% below the high.
₩35,450+₩50 (+0.14%)
Chong Kun Dang Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
₩7,560-₩130 (-1.69%)
Samil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.21% below the high.
₩8,070-₩160 (-1.94%)
Hana Pharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
₩8,560-₩270 (-3.06%)
Jeil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 55.62% below the high.
